Pulmonary arterial hypertension
Last updated 28 Feb 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Pulmonary arterial hypertension is a progressive disorder characterised by abnormally high blood pressure (hypertension) in the pulmonary artery, the blood vessel that carries blood from the heart to the lungs. Pulmonary arterial hypertension is one form of a broader condition known as pulmonary hypertension. Pulmonary hypertension occurs when most of the very small arteries throughout the lungs narrow in diameter, which increases the resistance to blood flow through the lungs. To overcome the increased resistance, blood pressure increases in the pulmonary artery and in the right ventricle of the heart, which is the chamber that pumps blood into the pulmonary artery. Ultimately, the increased blood pressure can damage the right ventricle of the heart.
Video picks for Genetic conditionsVideo library
Description
Pulmonary arterial hypertension is a progressive disorder characterised by abnormally high blood pressure (hypertension) in the pulmonary artery, the blood vessel that carries blood from the heart to the lungs. Pulmonary arterial hypertension is one form of a broader condition known as pulmonary hypertension. Pulmonary hypertension occurs when most of the very small arteries throughout the lungs narrow in diameter, which increases the resistance to blood flow through the lungs. To overcome the increased resistance, blood pressure increases in the pulmonary artery and in the right ventricle of the heart, which is the chamber that pumps blood into the pulmonary artery. Ultimately, the increased blood pressure can damage the right ventricle of the heart.
Signs and symptoms of pulmonary arterial hypertension occur when increased blood pressure cannot fully overcome the elevated resistance. As a result, the flow of oxygenated blood from the lungs to the rest of the body is insufficient. Shortness of breath (dyspnea) during exertion and fainting spells are the most common symptoms of pulmonary arterial hypertension. People with this disorder may experience additional symptoms, particularly as the condition worsens. Other symptoms include dizziness, swelling (edema) of the ankles or legs, chest pain, and a rapid heart rate.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Ayerza syndrome
Familial primary pulmonary hypertension
FPPH
Idiopathic pulmonary hypertension
PAH
PPH
PPHT
Primary pulmonary hypertension
Sporadic primary pulmonary hypertension
Patient picks for Genetic conditions

Medicine
Macitentan for pulmonary arterial hypertension
Macitentan will be prescribed for you by a specialist doctor. Take one 10 mg tablet each day. Swallow the tablet whole with a drink of water. Common side-effects include respiratory infections and feeling tired or dizzy.
by Michael Stewart, MRPharmS

Medicine
Iloprost for pulmonary arterial hypertension
Treatment with iloprost nebuliser solution will be started for you in hospital. It will be prescribed for you by a specialist doctor. Iloprost may increase your tendency to bleed (such as nosebleeds). You also may feel faint and dizzy. Do not let young children or pregnant women remain in the same room with you while you use iloprost.
by Michael Stewart, MRPharmS

Medicine
Sildenafil for pulmonary arterial hypertension
Sildenafil will be prescribed for you by a specialist doctor. Every time you collect a supply, check that you have been given the same brand of tablets as before. If the appearance is not the same as usual, please speak with your doctor or pharmacist. Do not drink grapefruit juice while you are on sildenafil. The most common side-effects are headache, sickness, flu-like infections, diarrhoea and nosebleeds.
by Michael Stewart, MRPharmS

Heart health and blood vessels
Pulmonary embolism
A pulmonary embolism (embolus) is a serious, potentially life-threatening condition. It is due to a blockage in a blood vessel in the lungs. A pulmonary embolism (PE) can cause symptoms such as chest pain or breathlessness. It may have no symptoms and be hard to detect. A massive PE can cause collapse and death. PE usually happens due to an underlying blood clot in the leg - deep vein thrombosis (DVT). Prompt treatment is important and can be life-saving. Pregnancy, various medical conditions and medicines, immobility and major surgery all increase the risk of a PE. Anticoagulation, initially with heparin and then warfarin, or other oral blood thinning tablets, is the usual treatment for PE.
by Dr Rachel Hudson, MRCGP

Tests and investigations
Arterial blood gases
Changes in the body cause chemical reactions to occur within the body cells all the time. As part of these reactions, both acid and alkali products will result. These acids and alkali have to be carefully balanced within the body so the body's cells work normally and to avoid cell death. The body has a number of mechanisms to counteract changes in the acid-base balance. The most important of which are the lungs and kidneys. An arterial blood gas (ABG) test is a quick and reliable blood test which can help medical professionals determine the diagnosis and treatment required.
by Dr Caroline Wiggins, MRCGP

Chest and lungs
Pulmonary fibrosis
Pulmonary fibrosis is a serious lung disease where the tiny air sacs of the lungs (the alveoli) and the lung tissue next to the alveoli become damaged and scarred, resulting in lung fibrosis. The main symptom is shortness of breath that gradually gets worse. The cause is often not known but pulmonary fibrosis can be caused by a variety of underlying conditions. Treatments include treating any underlying cause in addition to steroids and other medicines. Increasingly lung transplantation may be considered.
by Dr Toni Hazell, FRCGP
Related patient information and medicines

Medicine leaflet
Macitentan for pulmonary arterial hypertension
About macitentan Type of medicine A vasodilator antihypertensive medicine Used for Pulmonary hypertension Also called Opsumit® Available as Tablets Pulmonary arterial hypertension (PAH) Pulmonary hypertension is a condition where there is too high a blood pressure in the arteries which supply blood to your lungs from your heart. ...narrowed so.

Medicine leaflet
Iloprost for pulmonary arterial hypertension
About iloprost Type of medicine A vasodilator antihypertensive medicine Used for Pulmonary arterial hypertension Also called Ventavis® Available as Nebuliser solution for inhalation Pulmonary arterial hypertension (PAH) Pulmonary hypertension is a condition where there is too high a blood pressure in the blood vessels which supply blood to your.

Medicine leaflet
Sildenafil for pulmonary arterial hypertension
About sildenafil for pulmonary arterial hypertension Type of medicine A vasodilator antihypertensive medicine Used for Pulmonary arterial hypertension Also called Revatio®; Granpidam® Available as Tablets and oral liquid medicine Pulmonary arterial hypertension (PAH) Pulmonary hypertension is a condition where there is too high a blood pressure in.

Patient information leaflet
Systemic sclerosis
Systemic sclerosis is a type of scleroderma, which means hard skin. If you have scleroderma, you have areas of hardening of the skin. This can give you a cough or make you feel breathless as the lungs can't work as well as usual. High blood pressure in the arteries of the lungs, called pulmonary arterial hypertension. This can make you feel faint,.

Patient information leaflet
Use of oxygen therapy in COPD
In some cases, oxygen is used in COPD:... How does oxygen help chronic obstructive pulmonary disease. Oxygen is used to take the strain off your heart, not your lungs. It helps to prevent something called 'pulmonary artery hypertension'. This is quite an unusual condition where the right-hand side of your heart gets worn out by trying to pump.

Patient information leaflet
Buerger's disease
Peripheral arterial disease caused by atheroma. See separate leaflet called Peripheral Arterial Disease for more details Peripheral arterial disease. Experimental treatments There are some other treatments for Buerger's disease that have been used in research and trials and may not be widely available. They include treatment with a medicine called.
Further reading and references
- Pulmonary arterial hypertension; MedlinePlus, National Library of Medicine.
- Austin ED, Loyd JE. The genetics of pulmonary arterial hypertension. Circ Res. 2014 Jun 20;115(1):189-202. doi: 10.1161/CIRCRESAHA.115.303404.
- Geiger H, Tinker RJ, Talbert J, Phillips JA III, Austin ED. Heritable Pulmonary Arterial Hypertension Overview. 2002 Jul 18 [updated 2026 Apr 9]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1485/
- Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC, Gruenig E, Janssen B, Koehler R, Seeger W, Eickelberg O, Olschewski H, Elliott CG, Glissmeyer E, Carlquist J, Kim M, Torbicki A, Fijalkowska A, Szewczyk G, Parma J, Abramowicz MJ, Galie N, Morisaki H, Kyotani S, Nakanishi N, Morisaki T, Humbert M, Simonneau G, Sitbon O, Soubrier F, Coulet F, Morrell NW, Trembath RC. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat. 2006 Feb;27(2):121-32. doi: 10.1002/humu.20285.
- Machado RD, Southgate L, Eichstaedt CA, Aldred MA, Austin ED, Best DH, Chung WK, Benjamin N, Elliott CG, Eyries M, Fischer C, Graf S, Hinderhofer K, Humbert M, Keiles SB, Loyd JE, Morrell NW, Newman JH, Soubrier F, Trembath RC, Viales RR, Grunig E. Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects. Hum Mutat. 2015 Dec;36(12):1113-27. doi: 10.1002/humu.22904. Epub 2015 Oct 12.
- Montani D, Gunther S, Dorfmuller P, Perros F, Girerd B, Garcia G, Jais X, Savale L, Artaud-Macari E, Price LC, Humbert M, Simonneau G, Sitbon O. Pulmonary arterial hypertension. Orphanet J Rare Dis. 2013 Jul 6;8:97. doi: 10.1186/1750-1172-8-97.
- Soubrier F, Chung WK, Machado R, Grunig E, Aldred M, Geraci M, Loyd JE, Elliott CG, Trembath RC, Newman JH, Humbert M. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D13-21. doi: 10.1016/j.jacc.2013.10.035.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

